Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
17.95
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Teva Pharmaceutical Industries ADR
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
24
25
Next >
Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®
June 12, 2023
From
Alvotech
Via
GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
June 09, 2023
Via
Benzinga
Is AbbVie or Amgen the Better Bargain Buy Right Now?
June 08, 2023
These elite drugmakers are both working through a number of headwinds.
Via
The Motley Fool
Teva Concludes Nationwide Opioids Settlement Agreement
June 08, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Why Teva Pharmaceutical Stock Is Jumping Today
May 18, 2023
Investors are reacting positively to Teva's new growth strategy.
Via
The Motley Fool
Teva Pharma Crumbles After First-Quarter Earnings Miss, Flat Sales
May 10, 2023
Teva reported absolutely flat sales in the first quarter and light earnings.
Via
Investor's Business Daily
Phil and Teva Pharmaceuticals Launch New Program to Improve Access to the Digihaler® Family of Inhalers to Support Asthma Management
June 06, 2023
From
Phil Inc.
Via
Business Wire
Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy?
June 05, 2023
It's unclear whether the pivot will be enough to halt its recent decline.
Via
The Motley Fool
Teva Presents Real-World Data for AUSTEDO® (deutetrabenazine) Tablets with 4-Week Patient Titration Kit at Psych Congress Elevate 2023
June 02, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva Pharmaceutical Clocks Lower Profits On Flat Q1 Sales, Sticks To Annual Guidance
May 10, 2023
Via
Benzinga
Teva Pharmaceutical Indus: Q1 Earnings Insights
May 10, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 25, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2023
May 25, 2023
Via
Benzinga
Teva to Present Data Demonstrating UZEDY™ (risperidone) Extended-Release Injectable Suspension Significantly Prolonged Time to Impending Relapse for Adults with Schizophrenia at the American Psychiatric Association’s 2023 Annual Meeting
May 20, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2023
May 18, 2023
Via
Benzinga
Why Is Alimera Sciences (ALIM) Stock Up 21% Today?
May 18, 2023
Alimera Sciences (ALIM) stock is taking off on Thursday after signing a major deal with EyePoint Pharmaceuticals (EYPT).
Via
InvestorPlace
Why Is Teva Pharmaceuticals (TEVA) Stock Up Today?
May 18, 2023
Teva Pharmaceuticals (TEVA) stock is climbing higher on Thursday after the pharmaceutical company announced a new growth strategy.
Via
InvestorPlace
Netflix, Synopsys, Madison Square Garden Entertainment And Other Big Stocks Moving Higher On Thursday
May 18, 2023
U.S. stocks traded mixed, with the Dow Jones dropping around 50 points on Thursday. Here are some big stocks recording gains in today’s session. Urstadt Biddle Properties Inc. (NYSE: UBP) shares surged...
Via
Benzinga
Teva Launches New “Pivot to Growth” Strategy
May 18, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories
May 17, 2023
Benzinga
Via
Benzinga
One More Quits US Pharma Lobby Group: AstraZeneca Follows Teva, AbbVie Footsteps
May 17, 2023
AstraZeneca Plc (NASDAQ: AZN) has decided to leave a U.S. drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), making it the third company to leave the group in the last...
Via
Benzinga
A Bitter Pill to Swallow: Teva's $235M Challenge to GSK Dismissed by Supreme Court
May 15, 2023
The U.S.
Via
Benzinga
AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets, New Once-Daily Formulation of AUSTEDO®, Now Available in the U.S.
May 15, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
May 12, 2023
Via
Benzinga
Teva Pharmaceutical Industries (TEVA) Q1 2023 Earnings Call Transcript
May 10, 2023
TEVA earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook
May 10, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Nasdaq, S&P 500 Futures Slip Ahead Of Inflation Data — But Analyst Hints It Still Might Be Ok To Be Bullish
May 10, 2023
Via
Benzinga
Disney, Occidental Petroleum And 3 Stocks To Watch Heading Into Wednesday
May 10, 2023
With US stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Investor Sentiment Improves Slightly Ahead Of Key Inflation Reports
May 10, 2023
The CNN Money Fear and Greed index showed slight improvement in overall sentiment among U.S. investors on Tuesday.
Via
Benzinga
Teva Shares Progress Toward Access to Medicines and Environmental Commitments, Meeting and Exceeding Several ESG Targets Ahead of Schedule
May 09, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.